Three epidemiologists discussed the challenge of uncovering the causes of diseases at the 6th Cutter Symposium at Harvard Chan School.
For immediate release: February 2, 2022 Boston, MA – The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus’s properties, according to a paper…
For immediate release: January 13, 2022 Boston, MA – Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV),…
For immediate release: Wednesday, December 1, 2021 Boston, MA – People who are vaccinated for SARS-CoV-2 but get breakthrough infections may be less likely to spread the virus because they shed it for a shorter period than unvaccinated…
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
CAUSALab investigates how to use data to support better decisions in medicine, public health, and policy.
Harvard T.H. Chan School of Public Health and the Second Affiliated Hospital, Zhejiang University School of Medicine announce collaborative program in clinical research
Harvard Chan School and the Second Affiliated Hospital, Zhejiang University School of Medicine in Hangzhou, China, announce collaborative program in clinical research.
A group of scientists from across the U.S. took a deep dive into the foundations of environmental justice research during a new two-day intensive course.
Harvard Chan School's Marc Lipsitch and Rebecca Kahn will help establish a new CDC center focused on epidemic forecasting and outbreak analytics.
Thirty graduate students and researchers from around the globe learned about the linkages between mental well-being and physical health outcomes in a new five-day online course in mid-July.